2,3,4,5-tetrahydroxypentanal has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossein, G | 1 |
| Halvaei, S | 1 |
| Heidarian, Y | 1 |
| Dehghani-Ghobadi, Z | 1 |
| Hassani, M | 1 |
| Hosseini, H | 1 |
| Naderi, N | 1 |
| Sheikh Hassani, S | 1 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Cancer of Ovary
| Article | Year |
|---|---|
Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
Topics: Blood Proteins; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystad | 2019 |